Added to YB: 2025-11-17
Pitch date: 2025-11-12
BAYN.DE [neutral]
Bayer Aktiengesellschaft
+36.9%
current return
Author Info
Lux Opes Research covers European companies. Lots of them. Sign up for the newsletter.
Company Info
Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil.
Market Cap
EUR 36.9B
Pitch Price
EUR 29.00
Price Target
N/A
Dividend
0.29%
EV/EBITDA
7.31
P/E
-10.20
EV/Sales
1.47
Sector
Pharmaceuticals
Category
turnaround
Bayer (BAYN Germany): operational lift from Crop Science, but litigation still overshadows the story
BAYN.DE (quick overview): Adj EBITDA +15% vs expectations driven by Crop Science margin recovery from efficiency programs. Pharma/Consumer Health in-line. Reiterated FY outlook but glyphosate litigation provisions expanded to €4B. CEO targets containment by 2026. Operational turnaround solid but re-rating capped until legal clarity.
Read full article (2 min)